Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism

Ann Intern Med. 2022 Feb;175(2):W14. doi: 10.7326/L21-0731.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Hemorrhage / chemically induced
  • Humans
  • Venous Thromboembolism* / drug therapy

Substances

  • Anticoagulants